2010 Press Releases

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009 | 2008

December 07, 2010: Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
November 23, 2010: Tengion to Present at Piper Jaffray 22nd Annual Health Care Conference
November 16, 2010: Tengion Advances Clinical Trial for Neo-Urinary Conduit(TM) in Bladder Cancer Patients
November 01, 2010: Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
October 27, 2010: Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
October 26, 2010: Tengion to Host Conference Call to Provide a Business Update and Report Third Quarter 2010 Financial Results on November 1, 2010
October 25, 2010: Tengion Announces First Implantation of Neo-Urinary Conduit(TM) in Initial Clinical Trial in Patients with Bladder Cancer
October 25, 2010: Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
October 19, 2010: Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
October 12, 2010: Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
September 29, 2010: Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
September 14, 2010: Tengion to Present at UBS Global Life Sciences Conference
September 13, 2010: Regenerative Cellular Therapy in Chronic Kidney Disease Extends Survival; Tengion Preclinical Study Published in American Journal of Physiology Renal Physiology
September 10, 2010: Tengion Adds The Johns Hopkins Hospital as an Additional Clinical Trial Site For Its Phase I Neo-Urinary Conduit(TM) Clinical Trial
September 07, 2010: Tengion to Present at Rodman & Renshaw 12th Annual Healthcare Conference
August 11, 2010: Tengion Provides Corporate and Product Development Update and Reports Second Quarter 2010 Financial Results
August 04, 2010: Tengion Announces Second Quarter 2010 Results
August 02, 2010: Tengion Appoints A. Brian Davis Chief Financial Officer
July 07, 2010: Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
June 17, 2010: Tengion Presents New Data Supporting its Organ Regeneration Platform(TM) at 8th Annual Meeting of the International Society for Stem Cell Research
May 26, 2010: Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
May 18, 2010: Tengion Reports First Quarter 2010 Financial Results
May 13, 2010: Tengion Announces First Quarter 2010 Financial Report and Conference Call
April 14, 2010: Tengion Completes Initial Public Offering

Investor Resources

TNGN(Common Stock)

Exchange	OTC BB (US Dollar)
Price	$0.70
Change (%)	0.10 (16.67%)
Volume	4,000
Data as of 05/20/13 4:00 p.m. ET Minimum 20 minute delay Refresh quote

What's New

December 07, 2010
Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting

Highlights Include Additional Efficacy Data in Large Animals with Chronic Kidney Disease and New Mechanism of Action Data Presented for the Neo-Kidney Augment(TM) Program EAST NORRITON, Pa., Dec. 7, 2010 /PRNewswire via COMTEX/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that data from the Company's Neo-Kidney Augment(TM), Neo-GI Augment(TM), and Neo-Urinary Conduit(TM) programs are being featured in several posters and oral presentations at the TERMIS N...

November 23, 2010
Tengion to Present at Piper Jaffray 22nd Annual Health Care Conference

EAST NORRITON, Pa., Nov. 23, 2010 /PRNewswire via COMTEX/ --Tengion, Inc (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming Piper Jaffray 22nd Annual Health Care Conference on Wednesday, December 1, 2010, at 9:30 a.m. EST. A live audio webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TNGN&item_id=3494808 or u...

Investor Tool Kit

	Print Page
	E-mail Page
	RSS Feeds
	E-mail Alerts
	IR Contact